Drugs / Soluble beta-1,3/1,6-glucan
last change Jul 2006 re-read 3 minutes ago

Soluble beta-1,3/1,6-glucan

Developed for
mucositis
Investigated by
Biotec Pharmacon ASA

Trials 1

200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00289003 Oct 2003 → Jul 2006 mucositis Biotec Pharmacon ASA Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Soluble beta-1,3/1,6-glucan ClinicalTrials.gov intervention name — accepted as the source's own label NCT00289003 ↗